New Frontiers in Medicinal Chemistry: In-Depth Analysis of DAC Technology
Following antibody-drug conjugates (ADCs), a new drug form known as “Degrader-Antibody Conjugate” (DAC) is gaining attention in the field of oncology and other diseases due to its unique “targeted protein degradation” mechanism. 1 What is DAC?DAC, short for Degrader-Antibody Conjugate, is an innovative drug conjugation technology. It cleverly combines the targeting specificity of monoclonal antibodies … Read more